Showing results (131-140 of 144) with videos related to
Sort By:
Pageof 15
Zeitschrift Fur Kardiologie|March 5, 2005
Sirolimus-eluting stent treatment for isolated proximal left anterior descending artery stenoses. Results from the prospective multi-center German Cypher RegistryA A Khattab, C W Hamm, J Senges, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 13, 2018
Application of the Bogossian formula for evaluation of the QT interval in pacemaker patients with stimulated left bundle branch blockK F Weipert, H Bogossian, P Conzen, et al.Heart (British Cardiac Society)|May 19, 2009
Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients?K R Bainey, Y Fu, C B Granger, et al.Der Anaesthesist|December 6, 2019
[Prehospital management of acute coronary syndrome in patients on long-term direct oral anticoagulant treatment]E Schneck, F K Schneck, J S Wolter, et al.Journal of Aerosol Medicine and Pulmonary Drug Delivery|June 14, 2012
Systemic delivery of atropine sulfate by the MicroDose Dry-Powder InhalerT E Corcoran, R Venkataramanan, R M Hoffman, et al.Deutsche Medizinische Wochenschrift (1946)|March 15, 2002
[Percutaneous revascularization of multivessel coronary disease using stents - a multicenter, prospective study]S Baldus, R Köster, R Küchler, et al.Circulation|November 3, 1998
Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa InvestigatorsL K Newby, R H Christenson, E M Ohman, et al.Circulation|December 6, 2001
Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromesM Roffi, D P Chew, D Mukherjee, et al.European Heart Journal|September 5, 2002
Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategyM Roffi, D P Chew, D Mukherjee, et al.The New England Journal of Medicine|October 31, 1996
Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA InvestigatorsE M Ohman, P W Armstrong, R H Christenson, et al.Pageof 15